Related Experiment Video
Updated: Apr 16, 2026
07:59
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.9K
Cancer biomarker detection: recent achievements and challenges
1Laboratory of Chemical Biology and Division of Biological Inorganic Chemistry, State Key laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin 130022, P. R. China. xqu@ciac.ac.cn.
Chemical Society Reviews
|March 6, 2015
Summary
Early cancer detection saves lives. This review highlights advances in cancer biomarker detection technologies, showing multidisciplinary approaches are key for future non-invasive diagnostics and personalized treatments.
Area of Science:
- Biomedical Engineering
- Molecular Diagnostics
- Oncology
Background:
- Early cancer detection significantly reduces mortality.
- Biomarkers (nucleic acids, proteins, metabolites, cells) aid in risk assessment, diagnosis, prognosis, and treatment prediction.
- Traditional cancer detection methods have limitations.
Purpose of the Study:
- To provide an overview of recent advances in cancer biomarker detection technologies.
- To highlight the potential of multidisciplinary approaches in cancer diagnostics.
- To discuss challenges and future directions in cancer biomarker evaluation.
Main Methods:
- Review of recent scientific literature on cancer biomarker detection.
- Analysis of representative examples across various biomarker types and detection approaches.
- Discussion of technological advancements and their clinical implications.
Main Results:
- Multidisciplinary, technology-based cancer diagnostics are emerging as powerful alternatives to traditional techniques.
- Various approaches demonstrate significant progress in detecting diverse cancer biomarkers.
- Point-of-care and individualized cancer diagnostics are becoming increasingly feasible.
Conclusions:
- Advancements in cancer biomarker detection are crucial for improving patient outcomes.
- Collaboration across diverse scientific fields is essential to overcome current challenges.
- Future efforts should focus on developing non-invasive, convenient tests for early and personalized cancer care.
